C6K Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Avalo Therapeutics Inc

Watchlist Manager

Watchlist

Price: 2.488 EUR 3.15% Market Closed

Market Cap: €238.9m

	Avalo Therapeutics Inc F:C6K	US
	MAP Aktif Adiperkasa Tbk PT IDX:MAPA	ID
	Modine Manufacturing Co NYSE:MOD	US
	CY4GATE SpA MIL:CY4	IT
H	Honeywell International Inc BMV:HON	US
N	Nippon Sheet Glass Co Ltd XMUN:NI9	JP
M	Medical Properties Trust Inc SWB:M3P	US
A	Anglo American Platinum Ltd XBER:RPHA	ZA
P	Primerica Inc F:PI7	US
A	Akebia Therapeutics Inc F:AX9	US
O	Oddity Tech Ltd NASDAQ:ODD	IL
A	Arix Bioscience PLC SWB:3HY	UK
C	Cronos Group Inc DUS:7CI	CA
G	Greatland Gold PLC ASX:GGP	AU
Q	Q2 Holdings Inc F:0Q2	US

Profitability Summary

Avalo Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

100%

Strong 3Y Average Gross Margin

105%

Gross Margin is Increasing

86% > 100%

Negative Operating Margin

-123 602%

Negative 3Y Average Operating Margin

-18 716%

Declining Operating Margin

-122% > -123 602%

Negative Net Margin

-132 642%

Negative 3Y Average Net Margin

-21 305%

Declining Net Margin

-146% > -132 642%

Negative Free Cash Flow Margin

-87 217%

Negative 3Y Average Free Cash Flow Margin

-14 686%

Declining Free Cash Flow Margin

-115% > -87 217%

Negative ROE

-72%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-281%

Declining ROIC

-115% > -428%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.